Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells
Open Access
- 2 October 2014
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 22 (1) , 76-86
Abstract
Interleukin-15 (IL-15) is a common γ-chain cytokine that has a significant role in the activation and proliferation of T and NK cells and holds great potential in fighting infection and cancer. We have previously shown that bioactive IL-15 in vivo comprises a complex of the IL-15 chain with the soluble or cell-associated IL-15 receptor alpha (IL-15Rα) chain, which together form the IL-15 heterodimer. We have generated DNA vectors expressing the heterodimeric IL-15 by optimizing mRNA expression and protein trafficking. Repeated administration of these DNA plasmids by intramuscular injection followed by in vivo electroporation in rhesus macaques resulted in sustained high levels of IL-15 in plasma, with no significant toxicity. Administration of DNAs expressing heterodimeric IL-15 also resulted in an increased frequency of NK and T cells undergoing proliferation in peripheral blood. Heterodimeric IL-15 led to preferential expansion of CD8+NK cells, all memory CD8+ T-cell subsets and effector memory CD4+ T cells. Expression of heterodimeric IL-15 by DNA delivery to the muscle is an efficient procedure to obtain high systemic levels of bioactive cytokine, without the toxicity linked to the high transient cytokine peak associated with protein injection.Keywords
This publication has 64 references indexed in Scilit:
- DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeProceedings of the National Academy of Sciences, 2013
- Interleukin-15 biology and its therapeutic implications in cancerTrends in Pharmacological Sciences, 2012
- A human memory T cell subset with stem cell–like propertiesNature Medicine, 2011
- Electroporation delivery of DNA vaccines: prospects for successCurrent Opinion in Immunology, 2011
- Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefitVaccine, 2010
- DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challengeProceedings of the National Academy of Sciences, 2009
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- IL‐15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3European Journal of Immunology, 2008
- Converting IL-15 to a superagonist by binding to soluble IL-15RαProceedings of the National Academy of Sciences, 2006
- Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporationCancer Gene Therapy, 2006